WHWK
Whitehawk Therapeutics, Inc. · Healthcare · Market cap $262.2M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.6M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Jul 30, 2026
Giacobello Scott M.
Whitehawk Therapeutics, Inc. (WHWK) has 17 SEC Form 4 filings (26 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 30, 2026.
Inside the rolling window, 3 insiders at Whitehawk Therapeutics, Inc. reported no open-market purchases and 14 open-market sales totaling $2.6M. The most active filer is CHIEF EXECUTIVE OFFICER Lennon David James with 6 filings. Insiders have net sold $2.6M over the trailing 6 months. The most recent open-market filing is a sale of 77,000 shares by CHIEF FINANCIAL OFFICER Giacobello Scott M., dated Apr 15, 2026, worth $297K.
- Industry:Biotechnology
- CEO:David J. Lennon
- Employees:29
- HQ:Morristown, NJ, US
- IPO:2017-08-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CHIEF FINANCIAL OFFICER | Sale | 77,000 | $297K | Apr 17 | +11.9% | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 141,600 | $585K | Apr 17 | +11.9% | SEC ↗ | |
| See remarks | Sale | 26,389 | $91K | Apr 15 | +17.9% | SEC ↗ | |
| See remarks | Sale | 92,460 | $337K | Apr 15 | +17.9% | SEC ↗ | |
| See remarks | Sale | 50,000 | $179K | Apr 13 | +32.6% | SEC ↗ | |
| See remarks | Sale | 6,596 | $23K | Apr 13 | +32.6% | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 14,500 | $49K | Apr 10 | +35.7% | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 102,395 | $359K | Apr 8 | +34.9% | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 94,087 | $323K | Apr 8 | +34.9% | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 63,945 | $217K | Apr 8 | +34.9% | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 26,858 | $93K | Apr 3 | — | SEC ↗ | |
Lennon David JamesFirst filing | CHIEF EXECUTIVE OFFICER | Sale | 5,100 | $17K | Mar 10 | — | SEC ↗ |
BALL BRYANFirst filing | See remarks | Sale | 1,834 | $6K | Mar 10 | — | SEC ↗ |
Giacobello Scott M.First filing | CHIEF FINANCIAL OFFICER | Sale | 2,594 | $9K | Mar 10 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does WHWK have?
Whitehawk Therapeutics, Inc. (WHWK) has 17 SEC Form 4 filings (26 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Jul 30, 2026.
When was the most recent SEC Form 4 filing for WHWK?
The most recent Form 4 filing for WHWK on Tracefour is dated Jul 30, 2026.
Who is the most active insider at WHWK?
The most active SEC Form 4 filer at WHWK in the rolling window is CHIEF EXECUTIVE OFFICER Lennon David James, with 6 filings.
What is the net insider flow at WHWK over the last 6 months?
Over the trailing 180 days, insiders at WHWK have net sold $2.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at WHWK in the current window?
Inside the rolling window, insiders at WHWK bought $0 and sold $2.6M based on SEC Form 4 filings.
Can I get alerts for WHWK insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Whitehawk Therapeutics, Inc. (WHWK). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Whitehawk Therapeutics, Inc. is in the Healthcare sector.